Matthias Durken
Overview
Explore the profile of Matthias Durken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
2578
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mirza A, Ritsert M, Tao G, Thakar H, Lobitz S, Heine S, et al.
Blood Adv
. 2024 Oct;
9(1):29-38.
PMID: 39418614
Gene addition and editing strategies for transfusion-dependent β-thalassemia have gained momentum as potentially curative treatment options, with studies showcasing their efficacy and safety. We report, to our knowledge, the first...
2.
Vollherbst J, Zaninetti C, Greinacher A, Durken M
Thromb Haemost
. 2024 Sep;
PMID: 39299272
No abstract available.
3.
Schultewolter J, Rissmann A, von Schweinitz D, Fruhwald M, Blattmann C, Fischer L, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893276
GCTs are developmental tumors and are likely to reflect ontogenetic and teratogenetic determinants. The objective of this study was to identify syndromes with or without congenital anomalies and non-syndromic defects...
4.
Bohm S, Wustrau K, Pachlopnik Schmid J, Prader S, Ahlmann M, Yacobovich J, et al.
Blood
. 2023 Nov;
143(10):872-881.
PMID: 37992218
Primary hemophagocytic lymphohistiocytosis (pHLH) is a life-threatening hyperinflammatory syndrome that develops mainly in patients with genetic disorders of lymphocyte cytotoxicity and X-linked lymphoproliferative syndromes. Previous studies with etoposide-based treatment followed...
5.
Mettmann V, Baumhoer D, Bielack S, Blattmann C, Friedel G, von Kalle T, et al.
Cancer Med
. 2023 Aug;
12(17):18219-18234.
PMID: 37548393
Background: To evaluate patient and tumour characteristics, treatment and their impact on survival in patients with a solitary pulmonary metastasis at first relapse of high-grade osteosarcoma. Procedure: Two-hundred and nineteen...
6.
Leinert J, Weis M, Maros M, Flachsenhaar C, Kosubek M, Durken M
Klin Padiatr
. 2022 Nov;
235(4):250-253.
PMID: 36347485
No abstract available.
7.
Karremann M, Neumaier-Probst E, Schlichtenbrede F, Beier F, Brummendorf T, Cremer F, et al.
Orphanet J Rare Dis
. 2020 Oct;
15(1):299.
PMID: 33097095
Background: Revesz syndrome (RS) is an extremely rare variant of dyskeratosis congenita (DKC) with only anecdotal reports in the literature. Methods: To further characterize the typical features and natural course...
8.
Kunz J, Lobitz S, Grosse R, Oevermann L, Hakimeh D, Jarisch A, et al.
Pediatr Blood Cancer
. 2019 Dec;
67(4):e28130.
PMID: 31867835
Background: Limited data on the prevalence and medical care of sickle cell disease (SCD) in Germany are available. Here, we make use of a patient registry to characterize the burden...
9.
Pfaff E, El Damaty A, Balasubramanian G, Blattner-Johnson M, Worst B, Stark S, et al.
Eur J Cancer
. 2019 Apr;
114:27-35.
PMID: 31022591
Purpose: Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive paediatric brain tumour with fatal outcome. The Individualised Therapy For Relapsed Malignancies In Childhood (INFORM) registry study offers comprehensive molecular...
10.
Marz M, Meyer S, Erb U, Georgikou C, Horstmann M, Hetjens S, et al.
Leuk Res
. 2018 Jul;
71:47-54.
PMID: 30005184
Despite the high prevalence of central nervous system (CNS) involvement in relapsing pediatric acute lymphoblastic leukemia (ALL), our understanding of CNS invasion is still vague. As lymphoblasts have to overcome...